Buy Mazdutide Peptide

In short

Mazdutide is sold here for laboratory research, in 1 size (10mg), starting at $100.00 a vial. Every batch arrives with a certificate naming the test that identified it, the test that measured its purity, and the date each was run. It is not an FDA-approved medicine. Research use only, and never for people or animals.

Mazdutide specifications

Mazdutide product specifications
Product name	Mazdutide
Formula	C207H317N45O65
Physical form	Freeze-dried powder — a solid cake in a sealed vial
Appearance	White to off-white cake
Sizes on this page	10mg
Purity specification	≥99% by RP-HPLC. The number for the lot you receive is whatever its own certificate says.
Identity check	Mass spectrometry, read against the mass this compound should have
Net content	Weighed per lot and reported separately from purity
Lot documentation	At the laboratory — each certificate posts here the day it clears
Storage	Sealed, cold and out of the light
Ships from	Santa Ana, California — same business day on verified in-stock orders placed before 12 PM Pacific
Intended use	Laboratory research only. Not for human or animal use.

What is Mazdutide, and what is it used for?

Chemically: molecular formula C207H317N45O65, average mass 4476 g/mol (PubChem CID 167312357). Those figures are what the identity test on a certificate is read against.

Class

Oxyntomodulin analogue acting as a dual GLP-1 receptor and glucagon receptor agonist, developed as IBI362.

Mechanism

Agonist at both the GLP-1 receptor and the glucagon receptor. Unlike survodutide, it is built on an oxyntomodulin backbone — oxyntomodulin being an endogenous proglucagon-derived peptide that naturally activates both receptors, so the molecule is an engineered version of a native dual agonist rather than a designed hybrid.

Where it appears in the literature

Investigational. Originating in peptide design work at Eli Lilly and developed by Innovent Biologics, principally in China, across obesity and type 2 diabetes and with programmes in further indications.

What is not established

No approval in the United States or European Union. The relative contribution of the glucagon arm is not established, as with the rest of this class.

Mazdutide for sale: 10mg vials, price per mg

Mazdutide cost, and Mazdutide price per mg by size

Mazdutide is sold in 1 size here, 10mg, from $100.00 a vial. Mazdutide cost starts at that figure for the smallest vial, and the Mazdutide price per mg in the second column is the number to compare between sizes. The per-mg column is the honest comparison between sizes; the two tier columns show what ten and twenty vials of one size bill at, because the volume discount is per size and mixed sizes do not combine.

Mazdutide sizes, cost per mg, and what each volume tier bills
Size	One vial	Per mg	10 vials −10%	20 vials −15%	Availability
Mazdutide 10mg	$100.00	$10.00	$900.00$9.00/mg	$1,700.00$8.50/mg	Backordered — waitlist

Mazdutide discounts: bulk pricing, Subscribe & Save, and codes

Three things move this price and nothing else does: how many vials of one size are on the order, whether that order repeats, and one code. The fourth column prices each route against the 10mg vial.

Mazdutide: every buying option, what it takes off, and what the 10mg vial bills under it
Buying option	Takes off	When it applies	10mg at this option
One vial, one time	—	Any order	$100.00
10–19 vials of one size	10%	This order	$900.00$90.00 a vial
20 vials of one size	15%	This order	$1,700.00$85.00 a vial
Subscribe, every 1 month	6%	Shipment 2 onward	First $100.00, then $94.00
Subscribe, every 2 months	4%	Shipment 2 onward	First $100.00, then $96.00
Subscribe, every 3 months	2%	Shipment 2 onward	First $100.00, then $98.00
10 vials on a monthly subscription	10%, then 6% more	Shipment 2 onward	First $900.00, then $846.00
Sign-up code	10% of the order	One use, dead 24 hours after signup	$90.00 for one vial
Friday newsletter code	5% of the order	Live 24 hours, a new one each Friday	$95.00 for one vial
On-site offer code	5% of the order	Live 30 minutes from when it appears	$95.00 for one vial
Free standard shipping	The shipping charge	Orders over $200	3 vials

The first three stack; the codes do not. A volume discount comes off the line, a subscription cadence comes off that same line from shipment 2, and one code comes off what is left. One code per order, never two. A subscription runs a minimum of two shipments and can be cancelled once the second has shipped, and the first shipment always bills at today's eligible price with no cadence discount on it. The lowest this record ever bills is $7.99 per mg: twenty 10mg vials on a monthly subscription, from shipment 2 onward.

Every figure above is what you pay; nothing is added at checkout — dispatch and delivery work the same on every order.

Where to buy Mazdutide: five checks before you order from anyone

Where to get Mazdutide, and how to buy Mazdutide online

Mazdutide for sale, or Mazdutide peptide for sale, means this page: one record, 1 size, a lot certificate for each. You can buy Mazdutide online here with guest checkout; verified in-stock orders placed before 12 PM Pacific are dispatched the same day.

Run these on us too. A supplier who cannot pass them is asking you to take their word for it, and their word is the one thing a certificate exists to replace.

Check the certificate on the lab’s own site, not ours.
See whether it was written for the seller.
Match the lot number on the paper to the one on the vial.
Look for a method and a date next to every number.
Make sure identity was tested, not assumed.

Each of those is worked through, with what a failed check actually looks like, on verifying a certificate.

Mazdutide vs Tirzepatide and Retatrutide: different molecules, separate records

Mazdutide vs Tirzepatide, or Tirzepatide vs Mazdutide, is the comparison people search most, with Retatrutide close behind, and they are not the same thing. Each is a different molecule with a different formula, mass and research record, and each has its own certificate here.

Tirzepatide vs Mazdutide: the same comparison, side by side

Mazdutide compared with Tirzepatide and Retatrutide: what each record is
Record	Class	Formula	Avg. mass	Sizes here
Mazdutide	Oxyntomodulin analogue acting as a dual GLP-1 receptor and glucagon receptor agonist, developed as IBI362.	C207H317N45O65	4476	10mg from $100.00
Tirzepatide	A peptide that works on the GIP and GLP-1 receptors at the same time.	C225H348N48O68	4813	5mg · 10mg · 15mg · 20mg · 30mg · 40mg · 50mg · 60mg · 70mg · 80mg · 90mg · 100mg · 110mg · 120mg from $50.00
Retatrutide	An experimental peptide that works on three incretin receptors at once.	C221H342N46O68	4731.3	5mg · 10mg · 15mg · 20mg · 30mg · 40mg · 50mg · 60mg from $80.00

Documentation compared in full: Mazdutide vs Tirzepatide, side by side · Mazdutide vs Retatrutide, side by side.

The Mazdutide certificate: lot, purity, identity, and how to verify it

A certificate answers identity, purity and net content as three separate questions, each with the method that produced it and the date it was run — how to read one covers what each field does and does not cover. For Mazdutide that means a mass spectrum landing on 4,476 g/mol for C207H317N45O65, the figure published against PubChem CID 167312357.

The certificate below belongs to one lot, and its number matches the one printed on the vial you receive. A real report for a different batch is still the wrong report.

Mazdutide lot documentation by size
Size	Lot	Identity method	Purity	Test date
10mg	Pending verification	Pending verification	Pending verification	Pending verification

No lot documentation is published for Mazdutide yet. Rather than display a placeholder certificate, this record shows the gap until each field has been verified against the lot in hand. The certificate index lists every lot the moment its report clears.

Solution arithmetic for the bench, with no administration guidance: the vial concentration calculator, preset to Mazdutide.

Where the FDA stands on Mazdutide

Not an FDA-approved drug product

The FDA has not approved this compound for anything, and nothing in this catalogue is a medicine. Where a compound stands legally depends on what it is, what form it is in, what it is being used for and which country you are in, and it changes over time, so the status shown here carries the date it was last checked.

Status verified 2026-08-25. Regulatory positions move; check the primary source before relying on any summary, including this one.

It is sold here as laboratory material under the research-use restriction that closes this page, which is not an approval, and not a statement that the compound is safe, effective or right for any purpose.

Mazdutide research: what the published studies examine

Status: No FDA-approved application. This compound is sold as laboratory material. Where research on it has been published, it sits at the animal, cell or early-human stage, and this record does not summarise what it found. A supplier is not a neutral judge of evidence about its own catalogue.

Mazdutide is a dual GLP-1 and glucagon receptor agonist, and its distinguishing feature among the compounds on this catalogue is its starting point. Where retatrutide and survodutide are engineered hybrids, mazdutide derives from oxyntomodulin — a naturally occurring proglucagon-derived peptide that already activates both the GLP-1 and glucagon receptors. Nature, in other words, got to the dual-agonist idea first, and this molecule is a stabilised and extended version of that endogenous template rather than a construction from parts.

The practical consequence is the same receptor set as survodutide reached by a different route, and the same open question about how much the glucagon arm contributes.

Mazdutide: reported findings and the model each came from
Reported observation	Model	Source
A patent-landscape review across twelve patent families filed between 2015 and 2025 traces the compound from early oxyntomodulin-analogue peptide design at Eli Lilly through formulation, clinical and indication-expansion work led by Innovent Biologics, covering obesity, type 2 diabetes, hyperuricaemia and adolescent obesity, and characterises it as a dual GLP-1 receptor and glucagon receptor agonist.	patent landscape and development history review	Abdul Fasi, Patent landscape and therapeutic evolution of mazdutide: a dual GLP-1/glucagon receptor agonist for obesity and type 2 diabetes, Expert Opinion on Therapeutic Patents (2026)A patent and development review, not a pharmacology paper. It establishes provenance and receptor identity, not mechanism at the receptor level.
The mechanistic rationale for pairing glucagon receptor agonism with GLP-1 receptor agonism is described in the retatrutide characterisation: GLP-1 and GIP receptor agonism act on calorie intake while glucagon receptor agonism contributes through energy expenditure, which is the reason a glucagon arm is added rather than more GLP-1 potency.	recombinant receptor cell assays and obese mice	Coskun and colleagues, LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept, Cell Metabolism (2022)Cited for the class-level rationale behind glucagon-receptor agonism, not as a study of mazdutide.

Open questions. The indexed pharmacology specific to mazdutide is thinner than for the other incretins on this catalogue — the best available English-language source is a patent and development review rather than a receptor characterisation, and much of the clinical programme has run in China with results reported in venues that are harder to appraise from outside. That is a limitation on how confidently the compound can be described, not a criticism of the work. It is not approved in the United States or European Union.

The oxyntomodulin provenance is genuinely interesting and is also the kind of detail that gets used to imply the molecule is more natural and therefore safer, which does not follow: an engineered analogue of an endogenous peptide is still an engineered analogue. This page does not reproduce clinical efficacy endpoints.

That is a deliberate and consistent choice across every incretin compound on this catalogue: those results describe a supervised therapy given to patients under medical care, which is a different thing from laboratory material, and printing them beside a purchase control would blur that distinction rather than inform anyone. Tolerability findings from the same trials are reported, because how often a compound causes adverse events is a property of the compound.

Finally, the point that applies to every reseller including this one: a vial bearing one of these names is related to the developed molecule by claimed sequence identity alone, and that claim is exactly what an identity assay on the specific lot exists to test.

Each row above describes an observation in the stated model. None of it describes what Mazdutide would do in a person or an animal outside that model, and none of it is a recommendation to use it for anything.

Questions about Mazdutide

Where to buy Mazdutide Peptide, and can I get it online?

Here, in 1 size, with guest checkout and shipping across the United States. All sizes are on the waitlist at the moment, and typically return within 2 to 3 business days. Each size is tied to its own lot record, and a published certificate can be verified at the issuing laboratory before you order.

How much does Mazdutide Peptide cost?

$100.00 for the 10mg vial, and the table above shows cost per mg for each, which is the comparison that transfers between sizes.

What is the cheapest way to buy Mazdutide Peptide?

Twenty vials of one size on a monthly subscription. Ten to nineteen vials of a single size take 10% off and twenty take 15%, and mixed sizes do not combine toward either. A subscription then takes a further 6% monthly, 4% every two months or 2% every three, never on the first shipment and always from shipment 2 onward. One discount code comes off whatever is left, one code per order. On the 10mg vial that is $100.00 once, $85.00 a vial at twenty, and $7.99 per mg on recurring shipments. Standard shipping is free over $200, which 3 of the 10mg vials reach.

What is the FDA approval status of Mazdutide?

Not an FDA-approved drug product. The FDA has not approved this compound for anything, and nothing in this catalogue is a medicine. That is the position as at 2026-08-25, which is when it was last checked against the agency's own sources — approval status moves, and a date is the only thing that makes a status claim checkable. Being sold here for laboratory work is not an approval and not a safety claim.

What is Mazdutide used for?

In the published research, Investigational. No approval in the United States or European Union. The relative contribution of the glucagon arm is not established, as with the rest of this class. This record sells it for laboratory work and says nothing about use in a person or an animal.

Is Mazdutide legal?

Whether Mazdutide is legal depends on what it is being used for and where. It is sold here as laboratory material under a research-use restriction. Its FDA position: not an fda-approved drug product, status checked 2026-08-25. Being listed is not an approval and not a safety claim.

What is the difference between Mazdutide and Tirzepatide?

Mazdutide and Tirzepatide are different molecules. Mazdutide: Oxyntomodulin analogue acting as a dual GLP-1 receptor and glucagon receptor agonist, developed as IBI362. Tirzepatide: A peptide that works on the GIP and GLP-1 receptors at the same time. Each has its own formula, its own record on this site and its own certificate; a lot report for one says nothing about the other.

How does Mazdutide work, and what does it do?

At the level the published literature describes it, agonist at both the GLP-1 receptor and the glucagon receptor. No approval in the United States or European Union. The relative contribution of the glucagon arm is not established, as with the rest of this class. This record sells it for laboratory work and says nothing about use in a person or an animal.

What does Mazdutide peptide do?

What is Mazdutide peptide?

Mazdutide is oxyntomodulin analogue acting as a dual GLP-1 receptor and glucagon receptor agonist, developed as IBI362. Chemically: molecular formula C207H317N45O65, average mass 4476 g/mol (PubChem CID 167312357). It is sold here in a sealed vial with a certificate for the lot, for laboratory work only.

Is Mazdutide fda approved?

Not an FDA-approved drug product. The FDA has not approved this compound for anything, and nothing in this catalogue is a medicine. Status checked 2026-08-25. Being sold here for laboratory work is not an approval and not a safety claim.

How do I verify the certificate of analysis is real?

Check it at the issuing laboratory rather than with the seller: the report carries a verification key or QR that resolves on the laboratory's own site, and one with the key stripped out is worthless however it looks. Reading a certificate covers the rest. For Mazdutide the identity result should land on 4,476 g/mol for C207H317N45O65; a report whose mass is not that is either a different compound or a different form of it.

FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.